Quantitative analysis of the arterial pressure pulse waveform recorded by applanation tonometry of the radial artery can track NO (nitric oxide)-mediated modulation of arterial smooth muscle tone. The changes in pressure pulse waveform morphology result from pulse wave reflection arising predominantly from smaller arteries and arterioles. Employing Doppler ultrasound to record the spectral flow velocity waveform in the ophthalmic artery, we studied the effects of NO modulation on waveforms recorded in the proximity of the terminal ocular microcirculatory bed. In healthy young men (n = 10; age 18-26 years), recordings were made at baseline, following 300 µg of sublingual GTN (glyceryl trinitrate) and during the intravenous infusion of 0.25 and 0.5 mg/kg of L-NAME (N G -nitro-L-arginine methyl ester). Peaks (P1, P2 and P3) and nodes (N1, N2 and N3) on the arterial flow velocity waveform were identified during the cardiac cycle and employed to quantify waveshape change in response to the haemodynamic actions of the pharmacological interventions. The administration of GTN resulted in a significant (P < 0.05) increase in heart rate without significant alteration in blood pressure. At the doses employed, L-NAME did not significantly alter systemic haemodynamics. With the exception of peak Doppler systolic velocity, all other peaks and nodes decreased significantly in response to GTN (P < 0.05 for all points compared with baseline). In response to the administration of L-NAME, all peaks and nodes decreased significantly (P < 0.05 for all points compared with baseline). The resistive index, a ratio calculated from the peak and trough flow velocities employed to assess change in flow resistance, increased significantly in response to GTN (0.77 at baseline compared with 0.85; P < 0.05). Quantification of changes in the flow velocity spectral waveform during the cardiac cycle sensitively identified NO modulation of smooth muscle tone prior to alteration in systemic haemodynamics. Focusing on the resistive index, which identifies isolated points on the waveform describing the excursions of flow, may provide misleading information in relation to the haemodynamic effects of drug interventions.
A B S T R A C T
Quantitative analysis of the arterial pressure pulse waveform recorded by applanation tonometry of the radial artery can track NO (nitric oxide)-mediated modulation of arterial smooth muscle tone. The changes in pressure pulse waveform morphology result from pulse wave reflection arising predominantly from smaller arteries and arterioles. Employing Doppler ultrasound to record the spectral flow velocity waveform in the ophthalmic artery, we studied the effects of NO modulation on waveforms recorded in the proximity of the terminal ocular microcirculatory bed. In healthy young men (n = 10; age 18-26 years), recordings were made at baseline, following 300 µg of sublingual GTN (glyceryl trinitrate) and during the intravenous infusion of 0.25 and 0.5 mg/kg of L-NAME (N G -nitro-L-arginine methyl ester). Peaks (P1, P2 and P3) and nodes (N1, N2 and N3) on the arterial flow velocity waveform were identified during the cardiac cycle and employed to quantify waveshape change in response to the haemodynamic actions of the pharmacological interventions. The administration of GTN resulted in a significant (P < 0.05) increase in heart rate without significant alteration in blood pressure. At the doses employed, L-NAME did not significantly alter systemic haemodynamics. With the exception of peak Doppler systolic velocity, all other peaks and nodes decreased significantly in response to GTN (P < 0.05 for all points compared with baseline). In response to the administration of L-NAME, all peaks and nodes decreased significantly (P < 0.05 for all points compared with baseline). The resistive index, a ratio calculated from the peak and trough flow velocities employed to assess change in flow resistance, increased significantly in response to GTN (0.77 at baseline compared with 0.85; P < 0.05). Quantification of changes in the flow velocity spectral waveform during the cardiac cycle sensitively identified NO modulation of smooth muscle tone prior to alteration in systemic haemodynamics. Focusing on the resistive index, which identifies isolated points on the waveform describing the excursions of flow, may provide misleading information in relation to the haemodynamic effects of drug interventions.
INTRODUCTION
Characteristic changes in the arterial pressure pulse contour accompany risk factors for and disease states associated with an increase in cardiovascular events [1] [2] [3] . Typical alterations in arterial waveform morphology involve a steepening of the diastolic decay and diminution in the amplitude and duration of the oscillatory waveform that distorts the proximal part of diastole from a pure mono-exponential [2, 4] . The oscillatory component of the diastolic waveform arises from wave reflection and a damped resonance occurring in the arterial tree, with the major sites of reflected waves originating in smaller arteries and arterioles [5] . These changes described in waveform morphology, recorded by invasive and non-invasive techniques in large arteries, indirectly implicate altered structure and function in microvascular beds as the primary sites for vascular adaptations associated with aging and disease [4, 6] .
Clinical and experimental studies indicate that structural and functional changes in the microvasculature can predate or accompany risk factors for cardiovascular disease at the earliest stages in the disease process [7, 8] . Previous studies have employed Doppler waveform analysis, measured from a single arterial site, to record the spectral frequency envelope that can be displayed as a time-velocity waveform [9] . The systolic and diastolic blood flow velocity estimates derived from the timevelocity waveform provide information about the status of the vascular network downstream of the measurement site and have been employed to calculate vascular resistance [8, 10] . The accuracy of this approach to determine vascular resistance has been validated using embolization techniques in animal models [10, 11] . However, utilizing systolic and diastolic flow velocity estimates to track changes in resistance in response to pharmacological interventions can be inaccurate [10] . This is because changes in diameter and cross-sectional area of distal vascular beds will not only alter resistance to flow, but also the compliance characteristics of the network. Indeed the determination of flow resistance in microvascular beds derived from linear flow waveforms appears to be critically dependent upon the compliance characteristics of the microvascular bed [12] .
The ocular microcirculation represents a preferential target for many systemic diseases and changes in vessel structure can predate the development of hypertension by many years [8, 13] . NO (nitric oxide) is known to play a pivotal role in the control of ocular blood flow and has been implicated in contributing to development of local ocular and systemic vascular pathology [14] [15] [16] [17] [18] . We have shown previously [19] that quantitative analysis of arterial pressure pulse waveform morphology recorded from the radial artery can sensitively track changes in vasomotor tone in response to NO modulation. The purpose of the present study was to determine if analysis of linear velocity flow waveforms, recorded from the retrobulbar circulation, could identify and track changes in vascular tone in response to NO modulation.
METHODS

Participants
Ten young healthy male volunteers (age, 18-26 years; mean, 22 years) were recruited for the study. All subjects underwent a full history and examination including an ECG. Subjects were excluded if there was any history of ocular disease. No subjects were taking any medication at the time of study. Written informed consent was obtained from all subjects. The study was carried out in accordance with the Declaration of Helsinki (2000), and was approved by the local Ethical Committee of the Queen's University of Belfast.
Procedures
All studies were performed in the morning in a quiet temperature-controlled room. The subjects fasted overnight and refrained from consuming alcohol, tobacco or caffeine for 12 h prior to testing. An intravenous cannula was inserted into the right antecubital vein for infusion of drugs.
The eye to be examined was selected at random. Colour Doppler Ultrasonography examinations were performed by the same operator using an ATL ® HDI 3500 ultrasound machine with a 12.5 MHz linear array probe. Subject positioning, ultrasound technique and arterial vessel location were standardized for all participants. Subjects were studied supine with their head comfortably supported on a pillow and maintained fixation with their non-examined eye on a point marked on the ceiling directly above their head. The operator sat behind the subject's head and placed the ultrasound probe, coupled with gel, lightly on the closed eyelid of the subject. Ultrasound image quality was optimized and the machine settings were kept constant for the remainder of the entire examination. Colour imaging mode was used to locate the OA (ophthalmic artery) as it coursed along the medial side of the optic nerve. Pulsed Doppler recordings of flow velocity were made using a standard gate size of 1.5 mm, with the Doppler angle maintained under 60
• as described previously [22] . A 'Cineloop ® ' recording of the OA image was saved together with the gate depth and Doppler angle in order to relocate the same part of the vessel for subsequent measurements. The cuff of a semi-automatic sphygmomanometer was placed on the subject's left arm to permit arterial blood pressure measurement. Each subject's ECG trace was recorded in parallel to the OA blood flow velocity measurement.
Protocol
Subjects rested for 20 min in the supine position and an initial baseline OA ultrasound recording was obtained.
Figure 1 Typical ultrasound-derived OA blood flow velocity waveform
Peaks and nodes were identified on the mean OA flow velocity waveform. The three peaks (P1, P2 and P3) and nodes (N1, N2 and N3) used for analysis are identified.
Subjects rested for a further 5 min (with the probe removed from the eyelid) and a second baseline recording was obtained. Each subject received 300 µg of GTN (glyceryl trinitrate) sublingually. After 4 min, a further OA ultrasound recording was obtained and the remnants of the tablet removed. Following a 20 min washout period, l-NAME (N G -nitro-l-arginine methyl ester; 0.25 mg/kg) was infused at a rate of 2 ml/min for 8 min. An OA blood flow velocity recording was obtained after 4 min from the onset of the infusion. The infusion dose was doubled (0.5 mg/kg) and a final recording made 4 min after the dosage increase. The dose and infusion rates chosen were based on previous studies performed in this Department [19] . Each subject returned within 2 weeks when the protocol was repeated in an identical fashion.
Identification of analysis parameters
A 30-s train of blood flow velocity signals from the OA recorded at baseline and following each intervention were digitized at 200 Hz and exported to a PC using HDI ® lab software. The peak velocity envelopes of six consecutive flow velocity waveform signals were analysed in the time domain using customized software developed in the Department. Figure 1 represents a typical OA waveform. Peaks (P1, P2 and P3) and nodes (N1, N2 and N3) were identified on each flow velocity waveform, where P1 represents PSV (peak systolic velocity), and N3 represents EDV (end-diastolic velocity). The peaks and nodes, distributed throughout the cardiac cycle, were employed to quantify change in waveform morphology in response to drug interventions. These fiduciary points identified on the signals were averaged for the six waveforms to create a mean value for each feature. Previously only a 'peak ratio' (P2/P1), representing the ratio of the second to the first peak, or a resistive index [(P1 − N3)/P1] had been employed to characterize the flow velocity waveform [20] . However, this approach identifies isolated points on the waveform and cannot provide a comprehensive assessment of morphology change throughout the cardiac cycle in response to disease or drug interventions.
Statistical analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences software (SPSS ® , version 13.0). Data were analysed using ANOVA with multiple comparisons for homogeneous subsets. Haemodynamic data are represented by the means with 95 % confidence intervals. Average fiduciary points of the waveforms are represented by means + − 95 % confidence intervals, with data being regarded as statistically significant at a P value < 0.05. Components of variation analysis were used to assess within-and between-day reproducibility.
RESULTS
The effect of NO modulation on systemic haemodynamics and Doppler ultrasound parameters following the administration of GTN and l-NAME is shown in Table 1 . Mean arterial blood pressure did not change significantly with any intervention. The administration of GTN caused a significant increase in the heart rate compared with baseline. Figure 3 shows the mean OA Doppler flow velocity waveforms at baseline and following 300 µg of GTN administered sublingually. PSV did not change significantly in response to GTN; however, highly significant changes occurred in P2 and P3, and N1, N2 and N3, compared with baseline values, indicating the sensitivity of waveform parameters beyond peak flow measurements in identifying the haemodynamic action of the NO donor (P < 0.001 for all). The resistive index, a measure of flow velocity waveform pulsatility, increased significantly and paradoxically in response to GTN (P < 0.001; Table 1 ).
The administration of l-NAME did not significantly alter the systemic haemodynamics. Figure 4 represents the changes in waveform morphology at baseline and following l-NAME infused at 0.25 and 0.5 mg/kg. Both doses significantly decreased PSV and EDV when compared with baseline values (P < 0.05; Table 1 ). The resistive index was not significantly different when compared with the baseline values (Table 1) , as both PSV and EDV decreased by a similar magnitude. All peaks (P1, P2 and P3) and nodes (N1, N2 and N3) decreased significantly in response to the infusion of l-NAME when compared with baseline values (P < 0.001).
DISCUSSION
In the present study, we have shown that changes in the Doppler flow velocity spectral waveform can sensitively track haemodynamic change in the microvascular bed supplied by the OA in response to NO modulation. These waveshape changes were evident despite minimal alteration to systemic haemodynamics and reflect altered smooth muscle tone in the microcirculation distal to the site of measurement.
Microcirculatory abnormalities occur at the earliest stages in many pathogenic disease states and the ocular circulation, in particular, represents a preferential target for many disease processes [8, 13, 15, 16] . Critical analysis of arterial pressure pulse waveforms recorded from large arteries indicates that the earliest abnormalities in arterial structure and function associated with aging and disease reside in the microcirculation [7] . The ability to directly evaluate and monitor the status of specific microvascular beds of interest, rather than inferring general changes in the microcirculation from arterial waveforms recorded from large arteries, could hold therapeutic and prognostic potential.
Recent evidence indicates that recording the effects of wave reflection and its influence on wave shape in the proximity of vascular networks may yield information not apparent in recordings from large arteries due to energy dissipation and the destructive interaction of reflected components [21, 22] . Quantitative analysis of linear velocity flow waveforms provides important information in relation to the status of the ocular microvascular network. Microcirculatory networks are capable of increasing vessel diameter by 70-80 % compared with 5-10 % for muscular conduit arteries. The large changes in crosssectional area will influence the compliance characteristics of the network in addition to vascular resistance, as compliance change depends on geometry as well as change in vessel wall properties. Furthermore, given the vast surface area of endothelium in the microvasculature compared with conduit vessels, the earliest indications of endothelial dysfunction would be most apparent in this section of the vasculature.
Previous investigators have employed the resistive index, calculated from PSV and EDV flow estimates, as a clinically useful measure of vascular resistance distal to the site of measurement [9, [23] [24] [25] . In essence, the index represents a measure of pulsatility of the flow velocity waveform that correlates with the change in downstream vascular resistance. However, the resistive index may not accurately reflect an alteration in distal flow resistance in all circumstances [12, 26] . This is because waveform pulsatility depends on factors influencing both mean and pulsatile components of flow. It is the interaction of the compliance and resistance properties of the downstream arterial bed, which oppose pulsatile and steady components of flow respectively, that determines flow pulsatility and the resistive index [12] .
The interaction of these components is described by impedance or total opposition to flow presented by a vascular bed that influences the pattern of wave reflection and alters flow waveform morphology. Given these considerations it has been suggested that the resistive index should be more appropriately termed the 'impedance index' [12] . Furthermore, focusing solely on maximum and minimum excursions of flow pulsatility to derive the resistive index may not only provide misleading information, but also fail to identify important haemodynamic actions of pharmacological interventions that serve to alter flow waveform morphology.
The administration of l-NAME, a stereospecific inhibitor of endothelium-derived NO, significantly altered the linear velocity flow waveform morphology. As l-NAME reduced PSV and EDV to a similar degree, the haemodynamic action of this intervention would not have been detected by estimating the resistive index. The haemodynamic actions of the intervention were identified by addressing changes in other predefined features on the waveform that tracked altered morphology in response to the intervention. The most profound changes in waveform morphology were evident beyond peak systolic flow and occurred during late systole and diastole.
GTN is an NO donor that directly dilates vascular smooth muscle. Several groups have shown that GTN profoundly alters arterial waveform morphology without necessarily changing cardiac output or systematic vascular resistance [19, 27] . Organic nitrates preferentially influence the geometry and tone of small-and mediumsized arteries that impact on the pattern of wave reflection to alter waveform morphology. The resistance index paradoxically increased in response to GTN and indicated that this intervention increased vascular resistance. These data underscore the competing roles of changes in compliance and resistance of a vascular network influencing flow pulsatility and the derived resistance index [10, 12] .
In summary, we have shown that changes in the linear velocity waveform, derived from the OA, sensitively tracked changes in vasomotor tone in response to NO modulation. Altered waveform morphology resulted from changes in impedance matching and wave reflection that were indicative of changes in downstream resistance and compliance of microcirculatory beds.
